Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11752200 Methods of treating neurological disorders

Patent 11752200 was granted and assigned to EnClear Therapies on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

EnClear Therapies

Current Assignee

EnClear Therapies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Kasper Roet

Jonathan Fleming

Manuel A. Navia

Date of Patent

September 12, 2023

Patent Application Number

17153553

Date Filed

January 20, 2021

Patent Citations

US Patent 8292856 Implantable cerebral spinal fluid drainage system

US Patent 8435204 Cerebrospinal fluid purification system

US Patent 9097723 Method and apparatus for performing peptide digestion on a microfluidic device

US Patent 9421348 Systems and methods for moving and circulating fluid to treat alzheimer's disease

US Patent 9603792 System and method for correction of intracerebral chemical imbalances

US Patent 9629987 Systems and methods for shunting fluid

US Patent 9687670 Systems, devices, and methods including infection-fighting and monitoring shunts

US Patent 9744338 Systems and methods for shunting fluid

...

Patent Primary Examiner

Disclosed is a method for treating a subject having a neurological disorder characterized by the presence of toxic proteins comprising contacting the cerebrospinal fluid (CSF) of the subject with an agent capable of removing or degrading the toxic protein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11752200 Methods of treating neurological disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.